Product Information
RISEDRONATE SODIUM 5 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $1.4172 per EA under NDC 00093309956. Its NADAC has been published 119 times since Mar 20, 2024.
Strength
5 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093309956
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
RISEDRONATE SODIUM MONOHYDRATEApproval Type
Generic (ANDA)
FDA Application
ANDA077132On Market Since
6/1/2015
Pharmacological Classes
Price Statistics
The NADAC for RISEDRONATE SODIUM 5 MG TABLET has been published 119 times since Mar 20, 2024, and over the history we have for it it has declined 14.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.4172 per EA |
|---|---|
| All-time high | $1.7003 (Dec 10, 2025) |
| All-time low | $1.0715 (Feb 19, 2025) |
| 52-week high | $1.7003 |
| 52-week low | $1.3486 |
| Median price | $1.5047 |
| Average price | $1.4633 |
| Largest weekly change | -14.2% (Jan 22, 2025) |
| Weeks tracked | 119 |
| Tracking since | Mar 20, 2024 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of RISEDRONATE SODIUM 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for RISEDRONATE SODIUM 5 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $1.4172 per EA (NDC 00093309956), effective Jun 24, 2026.
How has the price of RISEDRONATE SODIUM 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for RISEDRONATE SODIUM 5 MG TABLET has declined 14.5%. It has been tracked across 119 weekly CMS publications since Mar 20, 2024.
What are the highest and lowest recorded NADAC prices for RISEDRONATE SODIUM 5 MG TABLET?
Since Mar 20, 2024, the NADAC for RISEDRONATE SODIUM 5 MG TABLET has ranged from a low of $1.0715 (Feb 19, 2025) to a high of $1.7003 (Dec 10, 2025), with a median of $1.5047 per EA.
Are there cheaper alternatives to RISEDRONATE SODIUM 5 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as RISEDRONATE SODIUM 5 MG TABLET, but none are currently priced below it.
Who manufactures RISEDRONATE SODIUM 5 MG TABLET?
RISEDRONATE SODIUM 5 MG TABLET (NDC 00093309956) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification